Adverum生物技術 ADVM 深 滬
等待開盤 01-29 09:30:00 美东时间
4.36
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.36
- 總市值 9149.11万
- 52周最高 5.75
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.78
- 委 比 0.00%
- 總股本 2098.42万
- 歷史最高 624.80
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.78
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Eli Lilly And Adverum Announce Expiration Of Tender Offer By Lilly Subsidiary To Acquire All Outstanding Adverum Shares For $3.56 Cash Plus Up To $8.91 Per Share In Contingent Value Rights, As Scheduled On December 8
Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM) today announced that the tender offer (the "Offer") by Flying Tigers Acquisition Corporation ("Purchaser"), a direct wholly-owned
2025-12-09 21:33
Adverum Urges Shareholders to Accept Eli Lilly Buyout Offering Up to $12.47 Per Share
Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy as a potential One And DoneTM treatment to preserve sight for life, today announced that it has
2025-12-01 20:26
Adverum Biotechnologies Faces Lease Termination Notice
An announcement from Adverum Biotechnologies ( ($ADVM) ) is now available. On N...
2025-11-22 05:41
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholder...
2025-11-11 06:30
Weekly Recap: 13 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new healthcare acquisitions, Halloween safety tips, and the adoption of AI in affordable heal...
2025-10-31 18:22
每日全球并购：纽曼矿业考虑收购巴里克矿业旗下内华达州金矿资产 | 青岛啤酒终止收购即墨黄酒（10/27）
-每日资讯- 1、纽曼矿业考虑收购巴里克矿业旗下内华达州金矿资产 纽曼矿业正在考虑通过潜在交易，获得竞争对手巴里克矿业旗下内华达州金矿资产的控制权。纽曼矿业已持...
2025-10-27 20:35
礼来加码基因疗法领域布局 押注一针复明的基因革命
①礼来宣布以每股3.56美元的价格收购美国生物科技公司Adverum Biotechnologies，并附带每股8.91美元的“或有价值权”； ②Ixo-vec是一种基因疗法，用于治疗“湿性年龄相关性黄斑变性”，目前已进入最后阶段的临床试验，并获得了FDA多项快速通道认定。
2025-10-24 23:53
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future milestones.
2025-10-24 23:14
基因治疗公司Adverum(ADVM.US)盘前跳涨！获礼来(LLY.US)收购要约
礼来公布了收购基因治疗公司Adverum Biotechnologies及其主要基因治疗候选药物Ixo-vec的计划。
2025-10-24 21:23
